Breaking
🇺🇸 FDA
Testosterone Therapy FDA Update: Key Regulatory Advances
Newstestosterone deficiency in menApr 27, 2026

Testosterone Therapy FDA Update: Key Regulatory Advances

The FDA has announced important regulatory advancements on testosterone therapy for men, focusing on improved safety monitoring and updated approval processes. Learn what this means for testosterone deficiency treatment.

Dr. Priya Sharma
GLP-1 Eating Disorder Risk: What You Need to Know
NewsObesity and type 2 diabetesApr 27, 2026

GLP-1 Eating Disorder Risk: What You Need to Know

Recent concerns about GLP-1 receptor agonists like semaglutide highlight potential eating disorder risks. This article reviews current evidence, FDA stance, and safety considerations.

Dr. Hannah O'Connor